Construction and Validation of a Necroptosis-Related Gene Signature for Predicting Prognosis and Tumor Microenvironment of Pancreatic Cancer

Figure 9

The expression difference of immune checkpoint genes between the two risk groups. (a) B7-H3 (CD276); (b) PD1 (PDCD1); (c) CTLA4; (d) TIGIT; (e) LAG3; (f) PD-L1 (CD274).

(a)

(b)

(c)

(d)

(e)

(f)